Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.500
-0.004 (-0.70%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $19.14 million as of December 20, 2024. Its market cap has decreased by -45.80% in one year.
Market Cap
19.14M
Enterprise Value
-16.48M
1-Year Change
-45.80%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $19.14M, a decrease of -97.23%. That is a compound annual growth rate of -60.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 19.14M | -55.00% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bionano Genomics | 20.45M |
| NKGen Biotech | 20.35M |
| Citius Pharmaceuticals | 19.86M |
| MiNK Therapeutics | 19.78M |
| Affimed | 19.34M |
| Impact BioMedical | 19.21M |
| BioLineRx | 19.08M |
| Concord Medical Services Holdings | 19.02M |